Boston Scientific/BSX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Boston Scientific
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Ticker
BSX
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Marlborough, United States
Employees
48,000
Website
www.bostonscientific.com
BSX Metrics
BasicAdvanced
$112B
Market cap
64.24
P/E ratio
$1.19
EPS
0.77
Beta
-
Dividend rate
Price and volume
Market cap
$112B
Beta
0.77
Financial strength
Current ratio
1.665
Quick ratio
0.942
Long term debt to equity
49.167
Total debt to equity
48.991
Dividend payout ratio (TTM)
0.79%
Interest coverage (TTM)
9.42%
Management effectiveness
Return on assets (TTM)
4.54%
Return on equity (TTM)
9.25%
Valuation
Price to earnings (TTM)
64.24
Price to revenue (TTM)
7.59
Price to book
5.64
Price to tangible book (TTM)
-98.43
Price to free cash flow (TTM)
65.21
Growth
Revenue change (TTM)
12.74%
Earnings per share change (TTM)
101.52%
3-year revenue growth
13.26%
3-year earnings per share growth
103.40%
What the Analysts think about BSX
Analyst Ratings
Majority rating from 34 analysts.
BSX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$3.9B
3.52%
Net income
$494M
-2.18%
Profit margin
12.81%
-5.46%
BSX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.53
$0.50
$0.55
$0.56
-
Expected
$0.49
$0.48
$0.51
$0.51
$0.58
Surprise
8.27%
4.86%
7.37%
9.19%
-
BSX News
AllArticlesVideos
Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation (BSX) an Upcoming Claims Deadline in a Class Action Settlement
Accesswire·2 months ago
Boston Scientific Elects Dr. Cheryl Pegus to Board of Directors
PRNewsWire·2 months ago
Levi & Korsinsky, LLP Notifies Shareholders of Boston Scientific Corporation (BSX) an Upcoming Claims Deadline in a Class Action Settlement
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Boston Scientific stock?
Boston Scientific (BSX) has a market cap of $112B as of July 03, 2024.
What is the P/E ratio for Boston Scientific stock?
The price to earnings (P/E) ratio for Boston Scientific (BSX) stock is 64.24 as of July 03, 2024.
Does Boston Scientific stock pay dividends?
No, Boston Scientific (BSX) stock does not pay dividends to its shareholders as of July 03, 2024.
When is the next Boston Scientific dividend payment date?
Boston Scientific (BSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Boston Scientific?
Boston Scientific (BSX) has a beta rating of 0.77. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Boston Scientific stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.